Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Principia Biopharma Inc (PRNB)

Principia Biopharma Inc (PRNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib

Trial enrolled patients ahead of originally anticipated timeline despite COVID-19 pandemic

PRNB : 100.05 (+0.10%)
Neoleukin Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Update

- NL-201 IND submission anticipated by year end 2020 -

NLTX : 13.96 (+1.45%)
PRNB : 100.05 (+0.10%)
Principia Announces First Patient Dosed in Phase 2A Trial of Rilzabrutinib in IgG4-Related Disease

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune mediated diseases,...

PRNB : 100.05 (+0.10%)
Neoleukin Therapeutics Announces Appointment of Martin Babler to Board of Directors

SEATTLE, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design  de novo...

NLTX : 13.96 (+1.45%)
PRNB : 100.05 (+0.10%)
Moore Kuehn Encourages SBPH, PFNX, VAR, and PRNB Investors to Contact Law Firm

NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...

SBPH : 4.8400 (unch)
VAR : 177.07 (-0.02%)
PRNB : 100.05 (+0.10%)
PFNX : 12.75 (-0.08%)
INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – PRNB, VAR, PTI, LVGO

NEW YORK, NY / ACCESSWIRE / September 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: Principia Biopharma Inc. (NASDAQ:PRNB) concerning potential violations...

PRNB : 100.05 (+0.10%)
VAR : 177.07 (-0.02%)
PTI : 1.1100 (-3.48%)
LVGO : 139.77 (-3.87%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of PRNB, CBMG, PFNX, and VAR Buyouts

WILMINGTON, Del., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

PRNB : 100.05 (+0.10%)
CBMG : 19.75 (unch)
VAR : 177.07 (-0.02%)
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – PRNB, BLDR, PFNX, MVC

NEW YORK, NY / ACCESSWIRE / September 1, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Principia Biopharma Inc. (NASDAQ:PRNB) concerning potential violations of...

PRNB : 100.05 (+0.10%)
BLDR : 184.55 (-2.63%)
PFNX : 12.75 (-0.08%)
MVC : 9.12 (+2.59%)
Lifshitz Law Firm, P.C. Announces Investigation of Cancer Genetics, Inc., Momenta Pharmaceuticals, Inc., Principia Biopharma Inc., and Yintech Investment Holdings Limited

NEW YORK, Sept. 01, 2020 (GLOBE NEWSWIRE) --

CGIX : 4.61 (-2.33%)
MNTA : 52.48 (-0.02%)
PRNB : 100.05 (+0.10%)
YIN : 7.25 (+0.14%)
SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – PRNB, MNTA, PTI, BLDR

NEW YORK, NY / ACCESSWIRE / August 29, 2020 /Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Principia Biopharma Inc. (NASDAQ:PRNB) concerning potential violations of the...

PRNB : 100.05 (+0.10%)
MNTA : 52.48 (-0.02%)
PTI : 1.1100 (-3.48%)
BLDR : 184.55 (-2.63%)

Barchart Exclusives

3 Gold Stocks to Buy as Israel Weighs Iran Response
With geopolitical tensions simmering after Iran's weekend missile launch on Israel, demand for gold stayed strong in Monday's session. For investors seeking safe-haven exposure to the asset, here are three gold stocks that analysts recommend. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar